Biocon Ltd. (BIOCON) Ltd Share Price Near 52-Week Low as Stock Trades at Rs 343.95
- October 13, 2026
- Posted by: Chaitanya Auti
- Category: News
Biocon Share Price traded at Rs 343.95, down 0.38%, and stayed near its 52-week low with a market capitalisation of Rs 56,794.84 crore. Univest data shows the move, but not a company-specific catalyst.
Biocon Share Price is trading at Rs 343.95 in morning trade on 13 October 2026, down 0.38% from the previous close of Rs 345.25. The move keeps Biocon Share Price close to its 52-week low and places Biocon Ltd. (BIOCON) firmly on the radar of investors tracking Biocon Share Price Today, Biocon Stock News and Biocon Share Price News. The company’s market capitalisation stands at Rs 56,794.84 crore, which keeps the stock in large-cap territory even as price action remains weak. Univest data confirms the near-low setup, but it does not establish a company-specific catalyst. For investors following Biocon Share Price Live, the key question is whether the current price zone reflects only short-term selling pressure or a broader valuation reset in the healthcare space.
Biocon Share Price matters today because the stock is moving near a one-year low while trading below important longer-term reference points. The latest pattern is useful for Biocon Stock Analysis because it combines price weakness with a high P/E profile and soft return ratios. For readers searching Biocon Share Price Today, Biocon Latest News and Biocon Share Price Update, the verified numbers point to a stock under pressure, with the next checkpoints being support around the day’s low, broad sector comparison and business performance context.
Biocon Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 343.95 |
| Previous Close | Rs 345.25 |
| Today's Move | Rs -1.3 (-0.38%) |
| Open | Rs 346.95 |
| High | Rs 346.95 |
| Low | Rs 342.4 |
| Market Capitalisation | Rs 56,794.84 crore |
Biocon Ltd. (BIOCON) traded at Rs 343.95 versus the previous close of Rs 345.25, a fall of 0.38%. The stock opened at Rs 346.95, reached a high of Rs 346.95, touched a low of Rs 342.4.
Biocon Share Price today was Rs 343.95, compared with the previous close of Rs 345.25, showing a day change of Rs -1.30 and a move of -0.38%. The stock opened at Rs 346.95, matched the day high at Rs 346.95 and touched a low of Rs 342.40. That range shows controlled but persistent selling pressure rather than a sharp intraday shock. With market capitalisation at Rs 56,794.84 crore, Biocon remains a significant listed healthcare company even as price action keeps Biocon Share Price close to its 52-week low. The latest Biocon Share Price Today move also leaves the stock near the lower end of its recent range, which is why traders watching Stocks in News and Stocks at 52 Week Low are likely to keep it on watch. Biocon Stock News today therefore centres on the price zone itself, not on any verified event trigger.
From a market structure angle, Biocon Share Price continues to trade below its 50-day moving average of Rs 384.86 and its 200-day moving average of Rs 398.50. That positioning suggests the stock is still in a weaker trend band and that rallies may meet supply until price rebuilds strength above those reference levels. For investors comparing Biocon Share Price Today with broader Share Market Today action, the picture remains one of pressure rather than recovery, which naturally leads into Biocon Technical Analysis and the way momentum is currently shaped.
Biocon Ltd. (BIOCON) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 56,794.84 crore |
| P/E Ratio | 113.6x |
| P/B Ratio | 1.66x |
| ROE | 1.35% |
| ROCE | 3.26% |
| EPS | Rs 3.04 |
| Book Value Per Share | Rs 208.53 |
| Dividend Yield | 0.14% |
Biocon Ltd. (BIOCON) fundamental metrics show P/E 113.6x, P/B 1.66x, ROE 1.35%, ROCE 3.26%. These figures provide context only and are not a buy or sell signal.
Biocon Ltd. has a market capitalisation of Rs 56,794.84 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 113.6x, P/B at 1.66x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 1.35% and ROCE of 3.26%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 3.04, book value per share of Rs 208.53, dividend yield of 0.14%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 27.66x, median ROE of 11.61%, median ROCE of 13.46%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 113.6x |
| Benchmark Median P/E | 27.66x |
| Benchmark Average P/E | 39.66x |
| Benchmark P/E Range | 0x to 676.52x |
| Company P/B Ratio | 1.66x |
| Benchmark Median P/B | 2.83x |
| Company ROE | 1.35% |
| Benchmark Median ROE | 11.61% |
| Company ROCE | 3.26% |
| Benchmark Median ROCE | 13.46% |
| Company Market Capitalisation | Rs 56,794.84 crore |
| Benchmark Median Market Cap | Rs 811.58 crore |
Biocon Ltd. (BIOCON) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.
Biocon Ltd. (BIOCON) has a P/E ratio of 113.6x, which is above the benchmark median of 27.66x, a difference of +310.7%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Biocon Ltd. (BIOCON) has a ROE of 1.35%, which is below the benchmark median of 11.61%, a difference of -88.37%. Biocon Ltd. (BIOCON) has a ROCE of 3.26%, which is below the benchmark median of 13.46%, a difference of -75.78%.
Track stocks falling to yearly lows through the Univest 52-week-low screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Abbott India Ltd. | ABBOTINDIA | 55,247.87 | 33.95 | 10.59 | 34.67 | 46.72 |
| Alkem Laboratories Ltd. | ALKEM | 62,953.96 | 28.96 | 4.37 | 18.29 | 21.28 |
| Gland Pharma Ltd. | GLAND | 50,527.97 | 45.01 | 4.78 | 10.56 | 14.96 |
| Glenmark Pharmaceuticals Ltd. | GLENMARK | 64,664.73 | 35.82 | 5.88 | 14.1 | 20.35 |
| Ipca Laboratories Ltd. | IPCALAB | 48,604.65 | 36.76 | 5.68 | 15.88 | 19.41 |
Biocon Ltd. (BIOCON) has a P/E ratio of 113.6x compared with the displayed peer median of 35.82x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 1.35% compares with a peer median of 15.88% across the companies shown in the table. ROCE stood at 3.26% versus the displayed peer median of 20.35%, providing a capital-efficiency comparison. Biocon Ltd. (BIOCON) has a market capitalisation of Rs 56,794.84 crore. Among the 5 peers shown, 2 have a larger market capitalisation.
Why Investors Are Watching Biocon
- Biocon Share Price is trading near its 52-week low, keeping Biocon Share Price Today in focus.
- Biocon Share Price is below the 50 DMA of Rs 384.86 and 200 DMA of Rs 398.50.
- Biocon Share Price shows a weak RSI of 33.17, which supports a cautious technical view.
- Biocon Fundamental Analysis highlights a high P/E of 113.6 alongside ROE of 1.35%.
- Biocon Share Price sits within the Healthcare sector where peer returns are materially stronger.
About Biocon
Biocon Ltd. operates in the Pharmaceuticals & Drugs industry within the Healthcare sector. The company is known for its biopharmaceutical and pharmaceutical business profile, and the latest quarter revenue provided in the record is Rs 4,336 crore for Jun 2026. That scale helps explain why Biocon Share Price continues to draw attention in Biocon Company News and Biocon Latest News searches.
Biocon Share Price also matters because the company’s market capitalisation is large enough to place it among the more prominent names in the industry. For investors looking at Biocon Share Price Live, the company’s business profile should be read alongside valuation, earnings power and sector positioning rather than on price movement alone. This is exactly the kind of context Univest uses to frame Biocon Stock News and Biocon Share Price Update coverage.
Track Biocon Share Price on Univest
Use Biocon Ltd. (BIOCON) live share-price page, Univest 52-week-low screener, Univest market blogs to review live stock data, yearly-low lists and related market analysis.
Readers can track Biocon Share Price on Univest for live share price updates, technical indicators, fundamental ratios, shareholding pattern insights, 52-week levels and market context. Univest presents Biocon Share Price Today alongside broader stock analysis so investors can follow price action, valuation and sector comparison in one place.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Registration Number INH000013776), a subsidiary of Univest Communication Technologies Private Limited.
Frequently Asked Questions
Why is Biocon Share Price near a 52-week low?
Ans. Biocon Share Price is near a 52-week low because the stock is trading below its key moving averages and the RSI is weak at 33.17. Univest data confirms the price zone, but it does not establish a company-specific trigger.
What is Biocon Share Price today?
Ans. Biocon Share Price is Rs 343.95, down 0.38% from the previous close of Rs 345.25. The stock opened at Rs 346.95 and touched a low of Rs 342.40 during the morning trade.
How expensive is Biocon compared with the healthcare industry?
Ans. Biocon trades at a P/E of 113.6 versus the industry median of 27.66 and average of 39.66. Its P/B of 1.66 is below the industry median of 2.83, so the valuation picture is mixed.
What do Biocon’s ROE and ROCE show?
Ans. Biocon reports ROE of 1.35% and ROCE of 3.26%, both below the same-industry medians. That suggests current return generation is weaker than the broader pharmaceuticals and drugs comparison set. ROE stands at 1.35%.
How does Biocon compare with pharma peers?
Ans. Biocon’s market cap of Rs 56,794.84 crore is comparable with several listed peers, but its P/E is much higher and its ROE and ROCE are lower than the latest Univest peer group. That makes valuation and returns important to monitor.